Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Rubinstein

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Stem Cells Translational Medicine|June 5, 2015
Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem CellsDavid Bar-Or, Gregory W Thomas, Leonard T Rael, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndromeManuel Hernández-Guerra, Juan Turnes, Pablo Rubinstein, et al.
Transfusion|March 26, 2018
Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors?Rodica Ciubotariu, Andromachi Scaradavou, Ilinca Ciubotariu, et al.
Transfusion|August 1, 2017
Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potencyM Susana Albano, Rodica Ciubotariu, Ludy Dobrila, et al.
Blood|August 24, 2006
Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screeningMaria S Albano, Patricia Taylor, Robert F Pass, et al.
Leukemia Research|January 23, 2003
Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administrationPunit D Wadhwa, Hillard M Lazarus, Omer N Koc, et al.
Transfusion|February 6, 2015
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusionsRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banksHenk G M Van der Zanden, Jon J Van Rood, Machteld Oudshoorn, et al.
Cytotherapy|April 1, 2011
Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord bloodStephen Spellman, Carolyn K Hurley, Colleen Brady, et al.
Blood|May 19, 2012
A perspective on the selection of unrelated donors and cord blood units for transplantationStephen R Spellman, Mary Eapen, Brent R Logan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Stem Cells Translational Medicine|June 5, 2015
Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem CellsDavid Bar-Or, Gregory W Thomas, Leonard T Rael, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndromeManuel Hernández-Guerra, Juan Turnes, Pablo Rubinstein, et al.
Transfusion|March 26, 2018
Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors?Rodica Ciubotariu, Andromachi Scaradavou, Ilinca Ciubotariu, et al.
Transfusion|August 1, 2017
Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potencyM Susana Albano, Rodica Ciubotariu, Ludy Dobrila, et al.
Blood|August 24, 2006
Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screeningMaria S Albano, Patricia Taylor, Robert F Pass, et al.
Leukemia Research|January 23, 2003
Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administrationPunit D Wadhwa, Hillard M Lazarus, Omer N Koc, et al.
Transfusion|February 6, 2015
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusionsRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banksHenk G M Van der Zanden, Jon J Van Rood, Machteld Oudshoorn, et al.
Cytotherapy|April 1, 2011
Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord bloodStephen Spellman, Carolyn K Hurley, Colleen Brady, et al.
Blood|May 19, 2012
A perspective on the selection of unrelated donors and cord blood units for transplantationStephen R Spellman, Mary Eapen, Brent R Logan, et al.
Pageof 3